12:00 AM
Jul 22, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Menarini, Vivus sales and marketing update

Vivus granted Menarini and its Berlin-Chemie AG/Menarini subsidiary exclusive rights to commercialize and promote erectile dysfunction (ED) drug Spedra avanafil in over 40 European countries, plus Australia and New...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >